ZA873928B - Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease - Google Patents

Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Info

Publication number
ZA873928B
ZA873928B ZA873928A ZA873928A ZA873928B ZA 873928 B ZA873928 B ZA 873928B ZA 873928 A ZA873928 A ZA 873928A ZA 873928 A ZA873928 A ZA 873928A ZA 873928 B ZA873928 B ZA 873928B
Authority
ZA
South Africa
Prior art keywords
topical
treatment
hyperproliferative epithelial
epithelial disease
methotrexate
Prior art date
Application number
ZA873928A
Other languages
English (en)
Inventor
Gerald D Weinstein
D Weinstein Gerald
Jerry L Mccullough
L Mccullough Jerry
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority to ZA873928A priority Critical patent/ZA873928B/xx
Publication of ZA873928B publication Critical patent/ZA873928B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA873928A 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease ZA873928B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86893686A 1986-05-30 1986-05-30
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Publications (1)

Publication Number Publication Date
ZA873928B true ZA873928B (en) 1988-02-24

Family

ID=25352598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Country Status (9)

Country Link
EP (1) EP0247900B1 (xx)
JP (1) JPS6327432A (xx)
AT (1) ATE70444T1 (xx)
CA (1) CA1300508C (xx)
DE (1) DE3775278D1 (xx)
DK (1) DK277387A (xx)
ES (1) ES2038663T3 (xx)
NZ (1) NZ220495A (xx)
ZA (1) ZA873928B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007874A1 (en) * 1991-10-26 1993-04-29 Ian Flockhart Medicament composition for topical application
WO1998031369A1 (fr) * 1997-01-16 1998-07-23 Sekisui Chemical Co., Ltd. Preparations a usage externe a absorption percutanee
KR100439204B1 (ko) * 2000-10-25 2004-07-07 주식회사 삼양사 메토트렉세이트를 유효성분으로 함유하는 경피투여용 조성물
BR102012009350B1 (pt) * 2012-04-20 2020-12-29 Biolab Sanus Farmacêutica Ltda composição farmacêutica tópica, processo de produção da composição farmacêutica tópica e uso da composição farmacêutica tópica
US20210186862A1 (en) * 2017-12-05 2021-06-24 Shilpa Medicare Ltd Methotrexate topical solution for treatment of psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553310A (en) * 1975-06-19 1979-09-26 Nelson Res & Dev Vehicle composition containing 1-substituted azacycloalkan-2-ones
GB2143433A (en) * 1983-06-20 1985-02-13 Hariprasad Manibhai Patel Methotrexate ointment
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4743588A (en) * 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents

Also Published As

Publication number Publication date
NZ220495A (en) 1990-07-26
CA1300508C (en) 1992-05-12
EP0247900B1 (en) 1991-12-18
ES2038663T3 (es) 1993-08-01
ATE70444T1 (de) 1992-01-15
DK277387A (da) 1987-12-01
JPS6327432A (ja) 1988-02-05
DE3775278D1 (de) 1992-01-30
EP0247900A1 (en) 1987-12-02
DK277387D0 (da) 1987-05-29

Similar Documents

Publication Publication Date Title
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
OA08581A (en) Treatment of diseases caused by retroviruses.
EP0151989A3 (en) Means for the treatment of cardiac diseases
BR9814857A (pt) Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
AU1808488A (en) Compounds for the treatment of alzheimer's disease
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
GB2188547B (en) Tamoxifen composition for the treatment of psoriasis.
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
JPS57122085A (en) Circulatory disease extirpenter and use
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
FR2651435B1 (xx)
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
IE870577L (en) Topical amide preparation
DE3373978D1 (en) Composition for the care or treatment of the human skin
DE3273389D1 (en) Derivatives of pentacyclo undecanes, processes for preparing these compounds, and pharmeceutical compositions thereof
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
HU9200400D0 (en) Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE3687448D1 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.
GR850484B (xx)
GR3000925T3 (en) 1-fluoro-1-halogeno-dioxa-3,6-bicycloû4.1.0¨heptane, preparation process and use